Clinical trial

Caprylic Triglyceride for Treatment of Cognitive Impairments in Multiple Sclerosis

NCT01848327

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2013-02-01

PhaseNA

Study timeline

Study start (actual)2013-02-01Date precision: month

Registry last updated2018-01-25

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Relapsing Remitting MSunresolved

Secondary Progressive MSunresolved

Primary Progressive MSunresolved

Interventions

Caprylic TriglycerideDIETARY_SUPPLEMENT

PlaceboDIETARY_SUPPLEMENT

Sponsors & collaborators

University of Miamilead sponsor

National Multiple Sclerosis Societycollaborator

Cerecincollaborator

Mapped research locations

MiamiFlorida, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01848327 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.